Anti-PDL1 as 3 line therapy in NSCLC

Date 20 November 2014
Event ESMO Preceptorship on Immunotherapy of Cancer 2014
Session Audience cases
Topics Non-Small-Cell Lung Cancer, Metastatic
Cancer Immunology and Immunotherapy
Presenter Marco Aiello
Authors M.M. Aiello
  • Catania/IT